Page last updated: 2024-10-31

mitoxantrone and Koch's Disease

mitoxantrone has been researched along with Koch's Disease in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, A1
Pal, SK1
Pandey, D1
Fakir, NA1
Rathod, S1
Sinha, D1
SivaKumar, S1
Sinha, P1
Periera, M1
Balgam, S1
Sekar, G1
UmaDevi, KR1
Anupurba, S1
Nema, V1
Nair, R1
Prabhash, K1
Sengar, M1
Bakshi, A1
Gujral, S1
Gupta, S1
Parikh, P1

Other Studies

2 other studies available for mitoxantrone and Koch's Disease

ArticleYear
PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.
    Annals of clinical microbiology and antimicrobials, 2017, Aug-18, Volume: 16, Issue:1

    Topics: Antitubercular Agents; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambut

2017
The effect of short-term intensive chemotherapy on reactivation of tuberculosis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxo

2007